Shares Magazine
11.25p+0.00 (+0.00%)04 Aug 2025, 15:40
Jump to:
Optibiotix Health PLC Fundamentals
| Company Name | Optibiotix Health PLC | Last Updated | 2025-08-04 |
|---|---|---|---|
| Industry | Biotechnology | Sector | Healthcare |
| Shares in Issue | 103.300 m | Market Cap | £11.62 m |
| PE Ratio | 9.50 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | -£0.02 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0 | Debt Equity Ratio | 0 |
| Asset Equity Ratio | 1.0770 | Cash Equity Ratio | 0.0880 |
| Quick Ratio | 3.1848 | Current Ratio | 3.87 |
| Price To Book Value | 1.3839 | ROCE | 0 |
Optibiotix Health PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Optibiotix Health PLC Company Financials
| Assets | 2024 | 2023 | 2022 |
|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 |
| Intangible Assets | £1.12 m | £1.33 m | £1.54 m |
| Investments | £6.50 m | £6.69 m | £8.15 m |
| Total Fixed Assets | £7.62 m | £8.02 m | £9.69 m |
| Stocks | £230,000.00 | £188,000.00 | £178,000.00 |
| Debtors | £433,000.00 | £460,000.00 | £521,000.00 |
| Cash & Equivalents | £739,000.00 | £635,000.00 | £1.05 m |
| Other Assets | 0 | 0 | 0 |
| Total Assets | £9.04 m | £9.40 m | £11.55 m |
| Liabilities | 2024 | 2023 | 2022 |
|---|---|---|---|
| Creditors within 1 year | £368,000.00 | £180,000.00 | £278,000.00 |
| Creditors after 1 year | £279,000.00 | £352,000.00 | £365,000.00 |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | £647,000.00 | £532,000.00 | £643,000.00 |
| Net assets | £8.40 m | £8.87 m | £10.90 m |
| Equity | 2024 | 2023 | 2022 |
|---|---|---|---|
| Called up share capital | £1.96 m | £1.82 m | £1.82 m |
| Share Premium | £4.11 m | £2.96 m | £2.96 m |
| Profit / Loss | -£1.87 m | -£2.04 m | £2.44 m |
| Other Equity | £8.40 m | £8.87 m | £10.90 m |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | £8.40 m | £8.87 m | £10.90 m |
| Ratios | 2024 | 2023 | 2022 |
|---|---|---|---|
| Debt Ratio | 0 | 0 | 0 |
| Debt-to-Equity | 0 | 0 | 0 |
| Assets / Equity | 1.0770 | 1.0770 | 1.0770 |
| Cash / Equity | 0.0880 | 0.0880 | 0.0880 |
| EPS | -£0.03 | -£0.02 | -£0.09 |
| Cash Flow | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash from operating activities | -£1.77 m | -£1.53 m | -£1.11 m |
| Cashflow before financing | -£483,000.00 | -£1.53 m | -£624,000.00 |
| Increase in Cash | £104,000.00 | -£417,000.00 | -£955,000.00 |
| Income | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | £870,000.00 | £644,000.00 | £457,000.00 |
| Cost of sales | £539,000.00 | £324,000.00 | £213,000.00 |
| Gross Profit | £331,000.00 | £320,000.00 | £244,000.00 |
| Operating Profit | -£2.27 m | -£1.70 m | -£2.49 m |
| Pre-Tax profit | -£1.87 m | -£2.04 m | £2.44 m |
Optibiotix Health PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company derives majority of the revenue from the sale of Functional Fibres. The company markets itsproducts in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics. |
| Latest Interim Date | 27 Sep 2024 |
| Latest Fiscal Year End Date | 30 Jun 2025 |
Optibiotix Health PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2025-06-30 | Mr. Richard Colin Neil Davidson CBE | Non-Executive Director,Chairman |
| 2013-11-18 | Mr. Leslie Christopher Barber | Non-Executive Director,chairman |
| 2013-11-18 | Mr. Clive Richard Garston | Non-Executive Director |
| 2017-12-29 | Mr. Adam Reynolds | Non-Executive Director |
| 2018-05-24 | Mr. David Eric Evans | Non-Executive Director,Chairman |
| 2023-06-28 | Mr. Christopher David Brinsmead CBE | Non-Executive Director |
| 2024-11-30 | Mr. Graham Lloyd Myers | Executive Director,Finance Director |
| 2013-02-05 | Mr. Norman Fetterman FCA | Non-Executive Director |
| 2015-05-29 | Dr. Mark Andrew Wyatt | Non-Executive Director |
| 2014-08-05 | Mr. Nicholas Christian Paul Nelson | Non-Executive Director |
| 2023-06-28 | Mr. Stephen William Hammond MP | Non-Executive Director |
| 2013-11-18 | Mr. Alexander Stuart Dowdeswell | Executive Director,Chief Executive Officer and Company Sec |
| 2025-06-30 | Mr. Stephen Patrick O'Hara | Executive Director,Chief Executive Officer |
| 2020-05-28 | Dr. Gareth Allan Barker | Non-Executive Director |
| 2018-05-23 | Mr. Robert Jim Laird | Executive Director,Commercial Director |
| 2020-05-28 | Mr. Per Rehne | Executive Director,Commercial Director |
| 2019-08-28 | Ms. Christina Mary Wood | Executive Director,Sales and Marketing Director |
| 2025-06-30 | Dr. Sofia Kolyda | Executive Director,Research and Development |
| 2025-06-30 | Mr. Michael Sean Christie | Non-Executive Director |
| 2021-03-23 | Mr. Frederic Narbel | Executive Director |
| 2023-02-21 | Mr. Rene Kamminga | Executive Director |
Optibiotix Health PLC Contact Details
| Company Name | OptiBiotix Health PLC |
|---|---|
| Address | Innovation Centre, Innovation Way, Heslington, York, YO10 5DG |
| Telephone | +44 1904435100 |
| Website | https://www.optibiotix.com |
Optibiotix Health PLC Advisors
| Solicitor | turnerparkinson LLP |
|---|
| Stockbroker | FinnCap |
|---|---|
| Phone | +44 2072200500 |
| Fax | +44 2072200597 |
| Registrar | Share Registrars Limited |
|---|---|
| Phone | +44 1252821390 |
| Fax | +44 1252719232 |
| Auditor | Jeffreys Henry LLP |
|---|---|
| Phone | +44 2073092222 |
| Fax | +44 2073092309 |
| Financial PR Adviser | Walbrook PR |
|---|---|
| Phone | +44 2079338780 |
| Fax | +44 2079338781 |
| Financial Adviser | Fisher Corporate Plc |
|---|---|
| Phone | 020 7388 7000 |
| Bank | HSBC Bank PLC |
|---|
| Nominated Adviser | Cairn Financial Advisers LLP |
|---|---|
| Phone | +44 2072130880 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Close Brothers Group PLC | 491.40 | 23.53 |
| Lloyds Banking Group PLC | 82.56 | 9.00 |
| Aston Martin Lagonda Global Holdings PLC | 71.60 | 6.79 |
| Watches Of Switzerland Group PLC | 346.20 | 5.94 |
| Ocado Group PLC | 349.10 | 5.56 |
| 4Imprint Group PLC | 3,735.00 | 5.21 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Auction Technology Group PLC | 376.00 | -21.67 |
| Senior PLC | 187.20 | -3.51 |
| Haleon PLC | 355.80 | -2.63 |
| Inchcape PLC | 672.00 | -2.04 |
| Rentokil Initial PLC | 354.30 | -2.02 |
| Pantheon Infrastructure PLC | 102.00 | -1.92 |